<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03417557</url>
  </required_header>
  <id_info>
    <org_study_id>CV-18-10</org_study_id>
    <nct_id>NCT03417557</nct_id>
  </id_info>
  <brief_title>Clinical Validation Study of Comfilcon A Multifocal Toric Contact Lenses</brief_title>
  <official_title>Clinical Validation Study of Biofinity Multifocal Toric Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to evaluate the clinical performance and subjective acceptance of an
      investigational contact lens (test), compared to a marketed lens (control) in an in-office
      setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a study to evaluate the clinical performance (including visual acuity, subjective
      assessments of visual performance, comfort ratings, vision preference and lens fit) of a
      comfilcon A investigational contact lens (test) compared to a control contact lens, in a
      non-dispensing setting. The main study hypothesis is the test contact lens will not be
      clinically inferior to the control lens.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 12, 2018</start_date>
  <completion_date type="Actual">April 3, 2018</completion_date>
  <primary_completion_date type="Actual">April 3, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This will be, prospective, single-masked, randomized, bilateral, cross-over, non-dispensing study comparing the test lens against the control lens.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>up to 3 hours</time_frame>
    <description>Visual acuity is assessed for test and control lens on a logMAR chart</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective Assessment of Visual Performance: Distance Day-time Navigation Tasks for Vision Quality and Clarity</measure>
    <time_frame>up to 3 hours</time_frame>
    <description>Subjective assessment of visual performance for distance day-time navigation tasks for vision/clarity was assessed for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Assessment of Visual Performance: Intermediate / Computer Task for Vision Quality and Clarity</measure>
    <time_frame>up to 3 hours</time_frame>
    <description>Subjective assessments of visual performance for intermediate / computer tasks for vision quality and clarity were assessed for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Assessment of Visual Performance: Near Vision for Vision Quality and Clarity</measure>
    <time_frame>up to 3 hours</time_frame>
    <description>Subjective assessments of visual performance for near vision was assessed for vision quality and clarity for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>Comfilcon A lens (test)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects are randomized to wear comfilcon A lens for up to 3 hours, either as first or second lens during this cross over study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Omafilcon B Lens (control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects are randomized to wear omafilcon B lens for up to 3 hours, either as first or second lens during this cross over study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Comfilcon A lens (test)</intervention_name>
    <description>contact lens</description>
    <arm_group_label>Comfilcon A lens (test)</arm_group_label>
    <other_name>Biofinity multifocal toric Lens (test)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Omafilcon B lens (control)</intervention_name>
    <description>contact lens</description>
    <arm_group_label>Omafilcon B Lens (control)</arm_group_label>
    <other_name>Proclear multifocal toric lens (control)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Has had a self-reported oculo-visual examination in the last two years.

          -  Is between ages 40â€”75 years, inclusive and has full legal capacity to volunteer.

          -  Has read and understood the information consent letter. Is willing and able to follow
             instructions and maintain the appointment schedule.

          -  Is able to participate in Parts A and B related to this work.

          -  Has a contact lens spherical prescription between +10.00 to 10.00D (inclusive).

          -  Has an Add component to their spectacle refraction (between +0.75 and +2.50DS).

          -  Has astigmatism between of -0.75 and -5.75DC (based on the calculated ocular
             refraction) in each eye.

          -  Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual
             vision correction or 20/25 best-corrected.

          -  Currently wears soft contact lenses.

          -  Has clear corneas and no active ocular disease.

          -  Has not worn lenses for at least 12 hours before the examination.

        Exclusion Criteria:

        A person will be excluded from the study if he/she:

          -  Has never worn contact lenses before.

          -  Has any systemic disease affecting ocular health.

          -  Is using any systemic or topical medications that will affect ocular health.

          -  Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to
             severe dry eyes) that would affect the wearing of contact lenses.

          -  Has persistent, clinically significant corneal or conjunctival staining using sodium
             fluorescein dye.

          -  Has any clinically significant lid or conjunctival abnormalities, active
             neovascularization or any central corneal scars.

          -  Is aphakic.

          -  Has undergone corneal refractive surgery.

          -  Is participating in any other type of eye related clinical or research study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University</name>
      <address>
        <city>Bloomington</city>
        <state>Indiana</state>
        <zip>47405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 25, 2018</study_first_submitted>
  <study_first_submitted_qc>January 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2018</study_first_posted>
  <results_first_submitted>January 14, 2020</results_first_submitted>
  <results_first_submitted_qc>January 14, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 10, 2020</results_first_posted>
  <disposition_first_submitted>December 19, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>December 19, 2019</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">December 24, 2019</disposition_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 9, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT03417557/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Three subjects did not meet the inclusion criteria. Seventeen (17) subjects completed all visits and were included in the analysis.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Comfilcon A Lens Then Omafilcon B Lens</title>
          <description>Subjects are randomized to wear comfilcon A lens for up to 3 hours then omafilcon B lens for up to 3 hours during this cross over study.
Comfilcon A lens (test): contact lens</description>
        </group>
        <group group_id="P2">
          <title>Omafilcon B Lens Then Comfilcon A</title>
          <description>Subjects are randomized to wear omafilcon B lens for up to 3 hours then comfilcon A lens up to 3 hours during this cross over study.
Omafilcon B lens (control): contact lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>1st Intervention (3 Hours)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>2nd Intervention (3 Hours)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Comfilcon A Lens (Test) and Omafilcon B (Control)</title>
          <description>Subjects were randomized to wear the comfilcon A (test) or omafilcon B (control) lens for up to 3 hours, either as first or second lens during this cross over study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>Visual acuity is assessed for test and control lens on a logMAR chart</description>
        <time_frame>up to 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Test)</title>
            <description>Subjects are randomized to wear comfilcon A lens for up to 3 hours during this cross over study.
Comfilcon A lens (test): contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B Lens (Control)</title>
            <description>Subjects are randomized to wear omafilcon B lens for up to 3 hours during this cross over study.
Omafilcon B lens (control): contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity</title>
          <description>Visual acuity is assessed for test and control lens on a logMAR chart</description>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Distance: Binocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.09"/>
                    <measurement group_id="O2" value="-0.03" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Distance: Monocular (dominate eye)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.12"/>
                    <measurement group_id="O2" value="0.06" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Distant: Monocular (non-dominate eye)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.13"/>
                    <measurement group_id="O2" value="0.13" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Near: Binocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.09"/>
                    <measurement group_id="O2" value="0.03" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Near: Monocular (dominate eye)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.11"/>
                    <measurement group_id="O2" value="0.17" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Near: Monocular (non-dominate eye)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.13"/>
                    <measurement group_id="O2" value="0.04" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Assessment of Visual Performance: Distance Day-time Navigation Tasks for Vision Quality and Clarity</title>
        <description>Subjective assessment of visual performance for distance day-time navigation tasks for vision/clarity was assessed for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.</description>
        <time_frame>up to 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Test)</title>
            <description>Subjects are randomized to wear comfilcon A lens for up to 3 hours during this cross over study.
Comfilcon A lens (test): contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B Lens (Control)</title>
            <description>Subjects are randomized to wear omafilcon B lens for up to 3 hours during this cross over study.
Omafilcon B lens (control): contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Assessment of Visual Performance: Distance Day-time Navigation Tasks for Vision Quality and Clarity</title>
          <description>Subjective assessment of visual performance for distance day-time navigation tasks for vision/clarity was assessed for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91" spread="8"/>
                    <measurement group_id="O2" value="79" spread="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Assessment of Visual Performance: Intermediate / Computer Task for Vision Quality and Clarity</title>
        <description>Subjective assessments of visual performance for intermediate / computer tasks for vision quality and clarity were assessed for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.</description>
        <time_frame>up to 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Test)</title>
            <description>Subjects are randomized to wear comfilcon A lens for up to 3 hours during this cross over study.
Comfilcon A lens (test): contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B Lens (Control)</title>
            <description>Subjects are randomized to wear omafilcon B lens for up to 3 hours during this cross over study.
Omafilcon B lens (control): contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Assessment of Visual Performance: Intermediate / Computer Task for Vision Quality and Clarity</title>
          <description>Subjective assessments of visual performance for intermediate / computer tasks for vision quality and clarity were assessed for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87" spread="12"/>
                    <measurement group_id="O2" value="82" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Assessment of Visual Performance: Near Vision for Vision Quality and Clarity</title>
        <description>Subjective assessments of visual performance for near vision was assessed for vision quality and clarity for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.</description>
        <time_frame>up to 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Comfilcon A Lens (Test)</title>
            <description>Subjects are randomized to wear comfilcon A lens for up to 3 hours during this cross over study.
Comfilcon A lens (test): contact lens</description>
          </group>
          <group group_id="O2">
            <title>Omafilcon B Lens (Control)</title>
            <description>Subjects are randomized to wear omafilcon B lens for up to 3 hours during this cross over study.
Omafilcon B lens (control): contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Assessment of Visual Performance: Near Vision for Vision Quality and Clarity</title>
          <description>Subjective assessments of visual performance for near vision was assessed for vision quality and clarity for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84" spread="17"/>
                    <measurement group_id="O2" value="79" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 3 hours per intervention.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Comfilcon A Lens (Test)</title>
          <description>Subjects are randomized to wear comfilcon A lens for up to 3 hours, either as first or second lens during this cross over study.
Comfilcon A lens (test): contact lens</description>
        </group>
        <group group_id="E2">
          <title>Omafilcon B Lens (Control)</title>
          <description>Subjects are randomized to wear omafilcon B lens for up to 3 hours, either as first or second lens during this cross over study.
Omafilcon B lens (control): contact lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Myhanh Nguyen, Sr. Optometrist</name_or_title>
      <organization>CooperVision</organization>
      <phone>19257306716</phone>
      <email>MNguyen@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

